In other countries
The same active substances on other registers, the same brand first.
- Cegfila (previously Pegfilgrastim Mundipharma)European Union · Mundipharma Corporation (Ireland) LimitedSame form
- DyrupegEuropean Union · CuraTeQ Biologics s.r.oSame form
- FulphilaEuropean Union · Biosimilar Collaborations Ireland LimitedSame form
- FulphilaCroatiaSame form
- GrasustekCroatiaSame form
- NeulastaCroatiaSame form
- FulphilaSaudi Arabia · Biocon LimitedSame form
- Grasustek 6 mg per 0.6 mlSaudi Arabia · USV Private Limited DamanSame form
- NeucyteSaudi Arabia · Biocon LimitedSame form
- NeulastaTaiwan · 注射劑 · 台灣大昌華嘉股份有限公司Same form
- FulphilaCanada · 10 MG / ML · Solution · Biocon Biologics Canada INCSame substance
- LapelgaCanada · 6 MG / 0.6 ML · Solution · Apotex INCSame substance
- LapelgaCanada · 6 MG / 0.6 ML · Solution · Apotex INCSame substance
- Fulphila 6 MG Solucion Inyectable en Jeringa PrecargadaSpain · 6 mg · solución inyectable · Biosimilar Collaborations Ireland LimitedSame substance
- NEULASTA 6 mg SOLUCION INYECTABLESpain · 6 mg · solución inyectable en jeringa precargada · Amgen Europe B.V.Same substance
- Pelgraz 6 MG Solucion Inyectable en Inyector PrecargadoSpain · 6 mg · solución inyectable · Accord Healthcare S.L.U.Same substance
- CegfilaItaly · Soluzione iniettabile in siringa pre-riempita · Mundipharma Corporation (Ireland) LimitedSame substance
- DyrupegItaly · Soluzione iniettabile in siringa pre-riempita · Curateq Biologics (Malta) LimitedSame substance
- FulphilaItaly · Soluzione iniettabile · Biosimilar Collaborations Ireland LimitedSame substance
- Cegfila 6 mg, oplossing voor injectie in voorgevulde spuitNetherlands · Oplossing voor injectie · Mundipharma Corporation (Ireland) LimitedSame substance
- Dyrupeg 6 mg oplossing voor injectie in voorgevulde spuitNetherlands · Oplossing voor injectie · CuraTeQ Biologics (Malta) LimitedSame substance
- Fulphila 6 mg, oplossing voor injectieNetherlands · Oplossing voor injectie · Biosimilar Collaborations Ireland LimitedSame substance
- ZiextenzoNew Zealand · Inj 6 mg per 0.6 ml syringeSame substance
- GRASUSTEK 6 mgRomania · 10mg/ml · sol. inj. in seringa preumpluta · Juta Pharma GMBHSame substance
- NEULASTA 6mgRomania · 6mg · sol. inj. · Amgen Europe B.V.Same substance
- PELGRAZ 6 mgRomania · 6 mg · sol. inj. in seringa preumpluta · Accord Healthcare S.L.U.Same substance
- GrasustekSerbia · 6mg/0.6mL · rastvor za injekciju u napunjenom injekcionom špricu · Corapharm D.O.O.Same substance
- Ziextenzo®Serbia · 6mg/0.6mL · rastvor za injekciju u napunjenom injekcionom špricu · PredstavniŠTvo Sandoz Pharmaceuticals D.D. BeogradSame substance
- Ziextenzo®Serbia · 6mg/0.6mL · rastvor za injekciju u napunjenom injekcionom špricu · PredstavniŠTvo Sandoz Pharmaceuticals D.D. BeogradSame substance
- Fulphila™ Solution for Injection in Prefilled Syringe 6MG/0.6MLSingapore · 6 mg / 0.6 ml · injection, solution · Zuellig Pharma Pte. LTD.Same substance
- Neulastim Pre-filled Syringe 6mg/0.6mlSingapore · 6mg/0.6ml · injection, solution · Amgen Biotechnology Singapore Pte LTDSame substance
- Pelgraz Solution for Injection in pre-filled syringe 6mg/0.6mLSingapore · 6 mg/0.6 mL · injection, solution · Accord Healthcare Private LimitedSame substance
- ArmlupegUnited States · 6MG/0.6ML · injection · Lupin LTDSame substance
- FulphilaUnited States · 6MG/0.6ML · injectable · Mylan GMBHSame substance
- NeulastaUnited States · 6MG/0.6ML · syringe · AmgenSame substance
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Anvisa, Brazil
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions · Added 12 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Pegfilgrastim
- Register
- Brazil (Anvisa)
- Status
- Authorised
- Status in the register
- Ativo
- Authorised
- 31 Mar 2025
- Registration
- 105730107
- Marketing authorisation holder
- Aché Laboratórios Farmacêuticos S.A
- Procedure
- Registered